Previous contraceptive treatment relates to grey matter volumes in the hippocampus and basal ganglia

• Published in: Scientific reports 2019-07, Vol.9 (1), p.11003-8, Article 11003
• Main Authors: Pletzer, Belinda, Harris, TiAnni, Hidalgo-Lopez, Esmeralda
• Format: Article
• Language: English
• Subjects: 59/57; 631/378/2649; 631/378/368; Adult; Androgens; Basal ganglia; Basal Ganglia - anatomy & histology; Basal Ganglia - drug effects; Birth control; Brain; Contraception; Contraceptives; Contraceptives, Oral - pharmacology; Emotional disorders; Estrogens; Female; Gray Matter - anatomy & histology; Gray Matter - drug effects; Hippocampus; Hippocampus - anatomy & histology; Hippocampus - drug effects; Hormones; Humanities and Social Sciences; Humans; Menstrual cycle; Menstruation; Mood; Mood disorders; multidisciplinary; Organ Size - drug effects; Science; Science (multidisciplinary); Sex hormones; Steroids; Substantia grisea; Young Adult
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-019-47446-4

Oral contraceptive (OC) effects on the brain have gained increasing interest, but are highly controversial. Previous studies suggest that OC users have larger hippocampi, parahippocampi, fusiform gyri and Cerebelli. Preliminary evidence from one of those studies even suggests an effect of previous contraceptive use on the hippocampi of women who are not current users of OCs. Furthermore, more recent studies postulate an involvement of previous OC treatment in later development of mood disorders. To address the question whether previous OC treatment affects women’s brain structure later in life, high resolution structural images were obtained from 131 naturally cycling women. Among them, 52 women had never used OC before, 52 had previously used one OC for a continuous time period and 27 had previously used multiple contraceptives. The groups did not differ in gray matter volumes. Since endogenous sex hormones modulate gray matter volumes of the hippocampus and basal ganglia along the menstrual cycle, we hypothesize effects of OC use on these areas. Specifically, we hypothesize that a longer duration of previous OC treatment is related to larger hippocampi and larger basal ganglia. Indeed we found the duration of previous OC use to be positively correlated to hippocampal and basal ganglia volumes bilaterally. For the hippocampus, but not for the basal ganglia, this association disappeared after controlling for the time since discontinuation. These results suggest that for the hippocampus, but not for the basal ganglia, effects of previous contraceptive treatment are reversed after a time period comparable to treatment duration. These data question the immediate reversibility of OC effects on brain structure. Accordingly, some changes in the brain due to long-term contraceptive use, while subtle, may be long-lasting.